United Kingdom
|
CHIR-99021 (CAS: 252917-06-9)
|
| SKU-Pack Size | Availability | Size | Price | |
| EBC51076-1ML | In Stock | 1mL(10mM in DMSO) | £130.90 | |
| EBC51076-2MG | In Stock | 2mg | £75.90 | |
| EBC51076-5MG | In Stock | 5mg | £108.90 | |
| EBC51076-10MG | In Stock | 10mg | £174.90 | |
| EBC51076-25MG | In Stock | 25mg | £317.90 |
| Please Select The Country You Are In To Find Your Local Distributor. |
| CUlabSciences | Phone:+44 (0) 1232 330008 | |
| Cambridge House St Thomas' Place Ely, | E-mail:sales@culabsciences.co.uk | |
| United Kingdom | Cambridge CB27 9RD UK | Web:www.culabsciences.co.uk |
| Product Information | |||||||||||||||||||||
| Synonym(s) | GSK-3 Inhibitor XVI | ||||||||||||||||||||
| Chemical Name | 6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile | ||||||||||||||||||||
| Application | CHIR-99021 is a GSK-3α/β inhibitor | ||||||||||||||||||||
| CAS Number | 252917-06-9 | ||||||||||||||||||||
| Purity | ≥99.0% | ||||||||||||||||||||
| Molecular Weight | 465.34 | ||||||||||||||||||||
| Molecular Formula | C₂₂H₁₈Cl₂N₈ | ||||||||||||||||||||
| SMILES | N#CC(C=N1)=CC=C1NCCNC2=NC=C(C3=NC(C)=CN3)C(C4=CC=C(Cl)C=C4Cl)=N2 | ||||||||||||||||||||
| Target & IC50 | GSK-3α: IC50 = 10 nM GSK-3β: IC50 = 6.7 nM |
||||||||||||||||||||
| Solubility | DMSO: 78 mg/mL (167.62 mM) | ||||||||||||||||||||
| Preparing Stock Solutions |
|
||||||||||||||||||||
| Shipping | Gel Pack | ||||||||||||||||||||
| Storage | Store at -20°C | ||||||||||||||||||||
| Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. | ||||||||||||||||||||
| Product Description | |
CHIR 99021 is an aminopyrimidine derivate that is a selective and potent inhibitor of glycogen synthase kinase 3 (GSK-3). It is used to maintain human and mouse stem cell lines and, in combination with other reagents, to chemically reprogram somatic cells into stem cells. |
| Specific Protocols | |